Zerenia Clinic UK

Book an appointment

admin

Differences between Cannabis Extracts and Flower

[shared_counts location=”home-content” style=”icon”] 18 March 2024 Differences between Cannabis Extracts and Flower Author: Multidisciplinary Team at Zerenia Reviewed and Edited By: Guillermo Moreno-Sanz, Ph.D. Understanding the Differences Between Medical Cannabis Flowers and Medical Cannabis Extracts The use of cannabis for its medicinal properties traces back millennia, but modern advancements have revolutionised the ways in which […]

Differences between Cannabis Extracts and Flower Read More »

“Flower Power”: Controlled Inhalation of THC-Predominant Cannabis Flos Improves Health-Related Quality of Life and Symptoms of Chronic Pain and Anxiety in Eligible UK Patients

[shared_counts location=”home-content” style=”icon”] 15 November 2023 “Flower Power”: Controlled Inhalation of THC-Predominant Cannabis Flos Improves Health-Related Quality of Life and Symptoms of Chronic Pain and Anxiety in Eligible UK Patients Author: Multidisciplinary Team at Zerenia Reviewed and Edited By: Guillermo Moreno-Sanz, Ph.D. Abstract In November 2018, the UK’s Home Office established a legal route for

“Flower Power”: Controlled Inhalation of THC-Predominant Cannabis Flos Improves Health-Related Quality of Life and Symptoms of Chronic Pain and Anxiety in Eligible UK Patients Read More »

Khiron publishes clinical study on the effectiveness of its products at controlling chronic pain

[shared_counts location=”home-content” style=”icon”] 15 April 2023 Khiron publishes clinical study on the effectiveness of its products at controlling chronic pain Author: Multidisciplinary Team at Zerenia Reviewed and Edited By: Guillermo Moreno-Sanz, Ph.D. Data substantiates company’s position as a global leader in health care solutions. Key findings in the study include: 9 out of 10 patients

Khiron publishes clinical study on the effectiveness of its products at controlling chronic pain Read More »

The CBD-ilemma

[shared_counts location=”home-content” style=”icon”] 15 March 2023 The CBD-ilemma Author: Multidisciplinary Team at Zerenia Reviewed and Edited By: Guillermo Moreno-Sanz, Ph.D. The approval of epidyolex for the treatment of refractory pediatric epilepsy is providing an increasing body of evidence on the therapeutic potential of cannabidiol (CBD), which had already showed promise to address other clinical conditions

The CBD-ilemma Read More »